|
1
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bliss LA, Witkowski ER, Yang CJ and Tseng
JF: Outcomes in operative management of pancreatic cancer. J Surg
Oncol. 110:592–598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Apelqvist A, Li H, Sommer L, Beatus P,
Anderson DJ, Honjo T, de Angelis MH, Lendahl U and Edlund H: Notch
signalling controls pancreatic cell differentiation. Nature.
400:877–881. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Espinoza I and Miele L: Deadly crosstalk:
Notch signaling at the intersection of EMT and cancer stem cells.
Cancer Lett. 341:41–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Han F, Wu J, Lee SW, Chan CH, Wu
CY, Yang WL, Gao Y, Zhang X, Jeong YS, et al: The role of Skp2 in
hematopoietic stem cell quiescence, pool size, and self-renewal.
Blood. 118:5429–5438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oishi H, Sunamura M, Egawa S, Motoi F,
Unno M, Furukawa T, Habib NA and Yagita H: Blockade of delta-like
ligand 4 signaling inhibits both growth and angiogenesis of
pancreatic cancer. Pancreas. 39:897–903. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mazur PK, Einwächter H, Lee M, Sipos B,
Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G,
et al: Notch2 is required for progression of pancreatic
intraepithelial neoplasia and development of pancreatic ductal
adenocarcinoma. Proc Natl Acad Sci USA. 107:13438–13443. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizuma M, Rasheed ZA, Yabuuchi S, Omura N,
Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W,
et al: The gamma secretase inhibitor MRK-003 attenuates pancreatic
cancer growth in preclinical models. Mol Cancer Ther. 11:1999–2009.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Y, Su H, Li X, Guo G, Cheng L, Qin R,
Qing G and Liu H: The NOTCH ligand JAGGED2 promotes pancreatic
cancer metastasis independent of NOTCH signaling activation. Mol
Cancer Ther. 14:289–297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyamoto Y, Maitra A, Ghosh B, Zechner U,
Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM,
Wolfe MS, et al: Notch mediates TGF alpha-induced changes in
epithelial differentiation during pancreatic tumorigenesis. Cancer
Cell. 3:565–576. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thomas MM, Zhang Y, Mathew E, Kane KT,
Maillard I and di Magliano Pasca M: Epithelial Notch signaling is a
limiting step for pancreatic carcinogenesis. BMC Cancer.
14:8622014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vo K, Amarasinghe B, Washington K,
Gonzalez A, Berlin J and Dang TP: Targeting notch pathway enhances
rapamycin antitumor activity in pancreas cancers through PTEN
phosphorylation. Mol Cancer. 10:1382011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Long B and Wang Z: Role of Notch
signaling pathway in pancreatic cancer. Am J Cancer Res. 7:173–186.
2017.PubMed/NCBI
|
|
18
|
Hanlon L, Avila JL, Demarest RM, Troutman
S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, et
al: Notch1 functions as a tumor suppressor in a model of
K-ras-induced pancreatic ductal adenocarcinoma. Cancer Res.
70:4280–4286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morgan MM and Mahowald AP: Multiple
signaling pathways establish both the individuation and the
polarity of the oocyte follicle in Drosophila. Arch Insect
Biochem Physiol. 33:211–230. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ellisen LW, Bird J, West DC, Soreng AL,
Reynolds TC, Smith SD and Sklar J: TAN-1, the human homolog of the
Drosophila notch gene, is broken by chromosomal
translocations in T lymphoblastic neoplasms. Cell. 66:649–661.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Piccirilli D, Baldini E, Massimiani M,
Camaioni A, Salustri A, Bernardini R, Centanni M, Ulisse S, Moretti
C and Campagnolo L: Thyroid hormone regulates protease expression
and activation of Notch signaling in implantation and embryo
development. J Endocrinol. 236:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hussain M, Xu C, Ahmad M, Yang Y, Lu M and
Wu X, Tang L and Wu X: Notch signaling: Linking embryonic lung
development and asthmatic airway remodeling. Mol Pharmacol.
92:676–693. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Chen SY, Zhao XY, Zhang MC and Xie
HT: Rat limbal niche cells prevent epithelial stem/progenitor cells
from differentiation and proliferation by inhibiting Notch
signaling pathway in vitro. Invest Ophthalmol Vis Sci.
58:2968–2976. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu Z, Zou Y, Fan J, Li C and Ma L: Notch1
is associated with the differentiation of human bone marrow-derived
mesenchymal stem cells to cardiomyocytes. Mol Med Rep.
14:5065–5071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williams E, Villar-Prados A, Bowser J,
Broaddus R and Gladden AB: Loss of polarity alters proliferation
and differentiation in low-grade endometrial cancers by disrupting
Notch signaling. PLoS One. 12:e01890812017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Irles P, Elshaer N and Piulachs MD: The
Notch pathway regulates both the proliferation and differentiation
of follicular cells in the panoistic ovary of Blattella germanica.
Open Biol. 6:150192016. View Article : Google Scholar
|
|
27
|
Wang L, Song G, Liu M, Chen B, Chen Y,
Shen Y, Zhu J and Zhou X: MicroRNA-375 overexpression influences
P19 cell proliferation, apoptosis and differentiation through the
Notch signaling pathway. Int J Mol Med. 37:47–55. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Doucas H, Mann CD, Sutton CD, Garcea G,
Neal CP, Berry DP and Manson MM: Expression of nuclear Notch3 in
pancreatic adenocarcinomas is associated with adverse clinical
features, and correlates with the expression of STAT3 and
phosphorylated Akt. J Surg Oncol. 97:63–68. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mann CD, Bastianpillai C, Neal CP, Masood
MM, Jones DJ, Teichert F, Singh R, Karpova E, Berry DP and Manson
MM: Notch3 and HEY-1 as prognostic biomarkers in pancreatic
adenocarcinoma. PLoS One. 7:e511192012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sjolund J, Manetopoulos C, Stockhausen MT
and Axelson H: The Notch pathway in cancer: Differentiation gone
awry. Eur J Cancer. 41:2620–2629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J
and Sarkar FH: Down-regulation of Notch-1 contributes to cell
growth inhibition and apoptosis in pancreatic cancer cells. Mol
Cancer Ther. 5:483–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Du X, Wang YH, Wang ZQ, Cheng Z, Li Y, Hu
JK, Chen ZX and Zhou ZG: Down-regulation of Notch1 by small
interfering RNA enhances chemosensitivity to gemcitabine in
pancreatic cancer cells through activating apoptosis activity.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 43:313–318. 2014.(In Chinese).
PubMed/NCBI
|
|
33
|
Yen WC, Fischer MM, Axelrod F, Bond C,
Cain J, Cancilla B, Henner WR, Meisner R, Sato A, Shah J, et al:
Targeting Notch signaling with a Notch2/Notch3 antagonist
(tarextumab) inhibits tumor growth and decreases tumor-initiating
cell frequency. Clin Cancer Res. 21:2084–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kunnimalaiyaan S, Trevino J, Tsai S,
Gamblin TC and Kunnimalaiyaan M: Xanthohumol-mediated suppression
of Notch1 signaling is associated with antitumor activity in human
pancreatic cancer cells. Mol Cancer Ther. 14:1395–1403. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Y, Zhu F, Xu S and Liu L: Anti-tumor
effect of the extract from qingyihuaji formula on pancreatic cancer
by down-regulating Notch-4 and Jagged-1. J Tradit Chin Med.
35:77–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
